Jiangbo Pharmaceuticals, Inc. (Jiangbo) is a holding company. Jiangbo operates, controls and owns the pharmaceutical business of Laiyang Jiangbo Pharmaceuticals Co., Ltd. (Laiyang Jiangbo). Laiyang Jiangbo researches, develops, manufactures, markets and sells pharmaceutical products and health supplements in the Peoples Republic of China. Laiyang Jiangbo pharmaceutical companies in China producing tablets, capsules, granules, syrup , mixture, pillselectuary and oral solution for both Western medical drugs and Chinese herbal-based medical drugs. Approximately 33.3% of its products are Chinese herbal-based drugs and 66.7% are Western medical drugs. During the fiscal year ended June 30, 2010 (fiscal 2010), Laiyang Jiangbo’s top four products included Clarithromycin sustained-release tablets, Itopride Hydrochloride granules, Baobaole Chewable tablets and Radix Isatidis Disperable tablets.